FOR IMMEDIATE RELEASE
Award-winning omega-3 study receives prestigious recognition from The Nutrition Society
COSHOCTON, Ohio, August 2026 – AlaskOmega®, a leading supplier of highly concentrated omega-3 ingredients sourced from wild Alaska pollock, is proud to recognize Professor Parveen Yaqoob OBE and her collaborators for research named British Journal of Nutrition Paper of the Year 2025.
The award-winning study, “High-dose fish oil supplements are more effective than oily fish in altering the number and function of extracellular vesicles in healthy human subjects: a randomized, double-blind, placebo-controlled, parallel trial,” was conducted by researchers from Liverpool John Moores University, the University of Reading, and the University of Southampton.
Professor Yaqoob, Professor of Nutritional Physiology and Deputy Vice-Chancellor & Pro-Vice-Chancellor (Research & Innovation) at the University of Reading, presented the Paper of the Year Prize Lecture at The Nutrition Society Congress 2026 in Newcastle, England. Following the event, Professor Yaqoob shared that the lecture was very well received and thanked collaborators for their contributions to the award-winning research.
AlaskOmega supplied the omega-3 ingredients used throughout the study but had no involvement in the study design, data collection, statistical analysis, interpretation of results, or publication decisions.
Award-Winning Research in Omega-3 Science
Published in the British Journal of Nutrition in 2025, the 12-week randomized, double-blind, placebo-controlled, parallel trial examined the effects of omega-3 intake from high-dose fish oil supplementation compared with oily fish consumption on extracellular vesicles (EVs) in healthy adults.
Extracellular vesicles are microscopic particles released by cells into circulation and are increasingly studied for their potential role in cardiovascular physiology, including blood coagulation.
Participants receiving high-dose fish oil supplements showed a significant reduction in the number of circulating EVs and a decrease in EV-stimulated thrombin generation. Participants consuming oily fish at dietarily achievable levels did not demonstrate the same changes, despite both groups showing comparable increases in EPA and DHA in red blood cells.
The researchers identified EPA intake as a potential factor contributing to the differences observed between the groups. The supplement group received approximately 1.5 grams of EPA per day, compared with approximately 0.6 grams from the oily fish intervention.
As a parallel trial involving 42 participants, the findings are exploratory. The researchers noted that additional larger and longer-term studies are needed to confirm and further investigate the observations.
Supporting Research That Advances Nutrition Science
For AlaskOmega, the recognition reflects the importance of supporting rigorous, independent research that advances scientific understanding of omega-3 fatty acids.
“We are honored that AlaskOmega ingredients were selected for this important clinical trial, and we congratulate Professor Yaqoob and the entire research team on this prestigious recognition. Supporting independent scientific research is an important part of our commitment to the omega-3 industry. Studies like this help advance our collective understanding of EPA and DHA and open the door to continued research into their role in human nutrition,” said Steve Dillingham, Global Vice President of Sales at AlaskOmega.
Quality Ingredients Supporting Quality Research
AlaskOmega omega-3 ingredients are sourced from 100% wild Alaska pollock harvested from one of the world’s most responsibly managed fishery. Through a vertically integrated supply chain and manufacturing process, AlaskOmega emphasizes freshness, purity, sustainability, and traceability from source to finished ingredient.
AlaskOmega continues to support collaborations with universities and research institutions as scientists investigate omega-3 fatty acids and their potential applications in human nutrition.
Recognition of this research as the British Journal of Nutrition Paper of the Year 2025 highlights the value of well-designed, independent clinical research and the continued scientific interest in understanding the effects of EPA and DHA.
About the Study
Study: Sharman A, Zhou R, Pugh J, Close G, Fisk HL, Calder PC, Yaqoob P (2025). High-dose fish oil supplements are more effective than oily fish in altering the number and function of extracellular vesicles in healthy human subjects: a randomised, double-blind, placebo-controlled, parallel trial. British Journal of Nutrition 133: 934-944. doi: 10.1017/S0007114525000625.
The study was named British Journal of Nutrition Paper of the Year 2025. Professor Parveen Yaqoob presented the associated Paper of the Year Prize Lecture at The Nutrition Society Congress 2026 in Newcastle, England.
About AlaskOmega®
AlaskOmega® is a leading supplier of premium omega-3 and omega-7 concentrates derived from wild Alaska pollock. Through vertically integrated manufacturing, AlaskOmega delivers highly purified, sustainably sourced ingredients to dietary supplement and nutrition brands around the world. From source to finished ingredient, AlaskOmega is committed to freshness, quality, sustainabilty, and scientific excellence.
